Ian Bowles, CEO of Allocate Software, tells Proactiveinvestors that with good institutional support the value proposition is very compelling with the stock at 79p. He says that while he is now looking overseas for opportunities there still remains a significant opportunity for Allocate Software in its primary business here in the UK healthcare market; with 42% of the sector already using Allocate's programming, there remains 39% of the NHS still not using ANY rostering software. FULL ARTICLE
Proactive Investors brings you the buzz from the brokers, with a wrap of overnight comment from some of the biggest names in the London square mile. FULL ARTICLE
With news of the drilling of its first production well, 2012 looks set to be a busy one for Rodinia Lithium (CVE:RM), the development-stage Canadian mineral exploration company focused on lithium assets in North America and Argentina and Nevada, USA. FULL ARTICLE
Today on Proactive UK